{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30289391", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "22"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "14"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.5152/tjg.2018.17847"], "Journal": {"ISSN": "2148-5607", "JournalIssue": {"Volume": "30", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jan"}}, "Title": "The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology", "ISOAbbreviation": "Turk J Gastroenterol"}, "ArticleTitle": "Predictors of poor outcomes in 488 patients with herb-induced liver injury.", "Pagination": {"StartPage": "47", "EndPage": "58", "MedlinePgn": "47-58"}, "Abstract": {"AbstractText": ["Herb-induced liver injury (HILI) can lead to chronic liver injury, liver transplantation, or even death. This study aimed to identify the predictors of poor HILI outcomes, especially chronic HILI.", "Clinical data of 488 patients with HILI were retrospectively analyzed from a Chinese center between January 2010 and January 2014. Logistic regression and C-statistic were used to identify risk factors and prognostic models for HILI outcomes.", "In all patients, 69 (14.1%) developed chronic HILI, and 20 (4.1%) died due to liver injury or underwent liver transplantation. To predict the fatal HILI prognosis, the model for end-stage liver disease (MELD) with a C-statistic of 0.981 (95%CI 0.968-0.995) was better than Hy's law (C-statistic 0.569; 95%CI 0.449-0.689). The latency, course of peak alanine aminotransferase decreasing >50% after discontinuation of herb application, peak triglyceride value, and platelet count at liver injury onset were identified as independent risk factors for chronicity with the adjusted odds ratios of 1.268 (95% confidence interval [CI] 1.034-1.554), 2.303 (95%CI 1.588-3.340), 0.580 (95%CI 0.343-0.978), and 0.183 (95%CI 0.091-0.368), respectively. A prognostic model for chronic HILI based on these four factors yielded the best prediction with a C-statistic of 0.812 (95%CI 0.755-0.868), compared with MELD (C-statistic 0.506; 95%CI 0.431-0.581) and Hy's law (C-statistic 0.418; 95%CI 0.343-0.492).", "Model for end-stage liver disease can be used to predict the fatal prognosis of HILI. A long latency, slow recovery, and low triglyceride value and platelet counts are important determinants for chronic HILI."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "Zhu", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Niu", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Wang", "ForeName": "Jia-Bo", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "Wang", "ForeName": "Rui-Lin", "Initials": "RL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "Li", "ForeName": "Jian-Yu", "Initials": "JY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kassel University School of Electrical Engineering and Computer Science, Kassel, Germany."}], "LastName": "Ma", "ForeName": "Yan-Qi", "Initials": "YQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Zhao", "ForeName": "Yan-Ling", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Zhang", "ForeName": "Yan-Fang", "Initials": "YF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "He", "ForeName": "Ting-Ting", "Initials": "TT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "Yu", "ForeName": "Si-Miao", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Guo", "ForeName": "Yu-Ming", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Integrative Medical Center, 302 Military Hospital, Beijing, China."}], "LastName": "Zhang", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing, China."}], "LastName": "Xiao", "ForeName": "Xiao-He", "Initials": "XH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Industrial, Environmental and Social Medicine, Goethe University School of Medicine, Frankfurt, Germany."}], "LastName": "Schulze", "ForeName": "Johannes", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Turkey", "MedlineTA": "Turk J Gastroenterol", "NlmUniqueID": "9515841", "ISSNLinking": "1300-4948"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood"], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": ["blood", "etiology", "mortality"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["mortality"], "DescriptorName": "Liver Transplantation"}, {"QualifierName": [], "DescriptorName": "Logistic Models"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Platelet Count"}, {"QualifierName": [], "DescriptorName": "Predictive Value of Tests"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": ["blood"], "DescriptorName": "Triglycerides"}], "CoiStatement": "<b><i>Conflict of Interest:</i></b> The authors have no conflict of interest to declare."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Teschke R, Andrade RJ. Drug, herb, and dietary supplement hepatotoxicity. Int J Mol Sci. 2016;17 doi: 10.3390/ijms17091488. pii: E1488.", "ArticleIdList": ["10.3390/ijms17091488", "PMC5037766", "27608014"]}, {"Citation": "Drug-induced Liver Injury Study Group, Chinese Society of Hepatology, Chinese Medical Association. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221\u201341. doi: 10.1007/s12072-017-9793-2.", "ArticleIdList": ["10.1007/s12072-017-9793-2", "PMC5419998", "28405790"]}, {"Citation": "Zhu Y, Niu M, Chen J, et al. Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol. 2016;31:1476\u201382. doi: 10.1111/jgh.13323.", "ArticleIdList": ["10.1111/jgh.13323", "26896664"]}, {"Citation": "Lee WJ, Kim HW, Lee HY, Son CG. Systematic review on herb-induced liver injury in Korea. Food Chem Toxicol. 2015;84:47\u201354. doi: 10.1016/j.fct.2015.06.004.", "ArticleIdList": ["10.1016/j.fct.2015.06.004", "26165727"]}, {"Citation": "Branch of Hepatobiliary Diseases China Association of Chinese Medicine, Branch of Chinese Patent Medicine China Association of Chinese Medicine. Guidelines for the diagnosis and treatment of herb-induced liver injury. Chin J Integr Med. 2018 Mar 15; doi: 10.1007/s11655-018-3000-8. doi: 10.1007/s11655-018-3000-8. [Epub ahead of print]", "ArticleIdList": ["10.1007/s11655-018-3000-8", "10.1007/s11655-018-3000-8", "0"]}, {"Citation": "Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015;17 doi: 10.3390/ijms17010014. pii: E14.", "ArticleIdList": ["10.3390/ijms17010014", "PMC4730261", "26712744"]}, {"Citation": "B\u00e9nichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11:272\u20136. doi: 10.1016/0168-8278(90)90124-A.", "ArticleIdList": ["10.1016/0168-8278(90)90124-A", "2254635"]}, {"Citation": "Kamath PS, Kim WR Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD) Hepatology. 2007;45:797\u2013805. doi: 10.1002/hep.21563.", "ArticleIdList": ["10.1002/hep.21563", "17326206"]}, {"Citation": "Teschke R. Traditional Chinese medicine induced liver injury. J Clin Transl Hepatol. 2014;2:80\u201394.", "ArticleIdList": ["PMC4521264", "26357619"]}, {"Citation": "Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal traditional Chinese medicine and suspected liver injury: a prospective study. World J Hepatol. 2017;9:1141\u201357. doi: 10.4254/wjh.v9.i29.1141.", "ArticleIdList": ["10.4254/wjh.v9.i29.1141", "PMC5648988", "29085558"]}, {"Citation": "Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines (Basel) 2016;3 pii: E18.", "ArticleIdList": ["PMC5456249", "28930128"]}, {"Citation": "Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806\u201315. doi: 10.1038/clpt.2011.58.", "ArticleIdList": ["10.1038/clpt.2011.58", "21544079"]}, {"Citation": "Teschke R, Danan G. Diagnosis and management of drug-Induced liver injury (DILI) in patients with pre-existing liver disease. Drug Saf. 2016;39:729\u201344. doi: 10.1007/s40264-016-0423-z.", "ArticleIdList": ["10.1007/s40264-016-0423-z", "27091053"]}, {"Citation": "Da\u011f MS, Ayd\u0131nl\u0131 M, Ozt\u00fcrk ZA, et al. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol. 2014;25:41\u20135. doi: 10.5152/tjg.2014.4486.", "ArticleIdList": ["10.5152/tjg.2014.4486", "24918129"]}, {"Citation": "Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol. 2017;9:491\u2013502. doi: 10.4254/wjh.v9.i10.491.", "ArticleIdList": ["10.4254/wjh.v9.i10.491", "PMC5387361", "28443154"]}, {"Citation": "Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug induced liver injury at a Tertiary hospital in India: etiology, clinical features and predictors of mortality. Ann Hepatol. 2017;16:442\u201350. doi: 10.5604/01.3001.0009.8600.", "ArticleIdList": ["10.5604/01.3001.0009.8600", "28425415"]}, {"Citation": "Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50:439\u201346. doi: 10.3109/00365521.2014.958094.", "ArticleIdList": ["10.3109/00365521.2014.958094", "25639449"]}, {"Citation": "Reuben A. Hy\u2019s law. Hepatology. 2004;39:574\u20138. doi: 10.1002/hep.20081.", "ArticleIdList": ["10.1002/hep.20081", "14768020"]}, {"Citation": "Bessone F. Predicting fatalities in serious idiosyncratic drug-induced liver injury-a matter of choosing the best Hy\u2019s law. Transl Gastroenterol Hepatol. 2017;2:112. doi: 10.21037/tgh.2017.12.06.", "ArticleIdList": ["10.21037/tgh.2017.12.06", "PMC5763032", "29354769"]}, {"Citation": "Zhu Y, Li YG, Wang Y, et al. Analysis of Clinical Characteristics in 595 Patients with Herb-induced Liver Injury. Chin J Integr Trad West Med. 2016;36:44\u20138.", "ArticleIdList": ["26955676"]}, {"Citation": "Pang L, Yang W, Hou F. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury. Clin Res Hepatol Gastroenterol. 2018;42:48\u201356. doi: 10.1016/j.clinre.2017.08.003.", "ArticleIdList": ["10.1016/j.clinre.2017.08.003", "28927656"]}, {"Citation": "Medina-Caliz I, Robles-Diaz M, Garcia-Mu\u00f1oz B, et al. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. J Hepatol. 2016;65:532\u201342. doi: 10.1016/j.jhep.2016.05.003.", "ArticleIdList": ["10.1016/j.jhep.2016.05.003", "PMC7458366", "27184533"]}, {"Citation": "Stine JG, Chalasani N. Chronic liver injury induced by drugs: a systematic review. Liver Int. 2015;35:2343\u201353. doi: 10.1111/liv.12958.", "ArticleIdList": ["10.1111/liv.12958", "26346512"]}, {"Citation": "de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int. 2017;37:123\u20139. doi: 10.1111/liv.13306.", "ArticleIdList": ["10.1111/liv.13306", "28052628"]}, {"Citation": "Lo Re V, 3rd, Haynes K, Forde KA, et al. Risk of acute liver failure in patients with drug-induced liver injury evaluation of Hy\u2019s law and a new prognostic model. Clin Gastroenterol Hepatol. 2015;13:2360\u20138. doi: 10.1016/j.cgh.2015.06.020.", "ArticleIdList": ["10.1016/j.cgh.2015.06.020", "PMC4655161", "26122767"]}, {"Citation": "Tonomura Y, Kato Y, Hanafusa H, et al. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats. J Appl Toxicol. 2015;35:165\u201372. doi: 10.1002/jat.3053.", "ArticleIdList": ["10.1002/jat.3053", "25186495"]}, {"Citation": "Ou P, Chen Y, Li B, et al. Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital. Springerplus. 2015;4:802. doi: 10.1186/s40064-015-1600-8.", "ArticleIdList": ["10.1186/s40064-015-1600-8", "PMC4688287", "26702391"]}]}], "History": [{"Year": "2018", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30289391", "PMC6389292", "10.5152/tjg.2018.17847"]}}]}